Edesa Biotech Research, Inc.

---

Registration: 11 of 12 (2024-03-01 to 2024-09-01)

Details Regarding the Identified Subject Matter

Subject matters	Details	Categories
Health, Research and Development	Seeking funding to allow for increased research and development and other expenditures into two clinical-stage antibodies to treat acute respiratory distress syndrome (the primary cause of death from COVID-19) from the Industrial Research Assistance Program and the Strategic Innovation Fund.	Grant, Contribution or Other Financial Benefit